Drug Chatter -- Tracking biopharma stock chatter

Profile for Merrimack Pharmaceuticals, Inc. (MACK)

« Back to company index

MACK Chatter Timeline

Stock Ticker for MACK

Most Active Tweeters for MACK

UserTweets
@filingBot 5
@StockTexts 4
@TickerReport 4
@Allstocknews 4
@VisualStockRSRC 4

Recent Tweets for MACK

Re1axNtakeNotes @Re1axNtakeNotes
RT @DrSManian: $MACK Left for dead bottom Bio Could be the big turnaround story for 2018 New CEO Richard Peters ex $SNY New CMO Sergio S…
November 19th 2017, 7:11pm
DrSManian @DrSManian
$MACK Pre/split 60$ stock in 2015. If we see good data in Q1 has massive upside Current MC just 155M https://t.co/xIWsRwegJW
November 19th 2017, 3:11pm
DrSManian @DrSManian
$MACK Left for dead bottom Bio Could be the big turnaround story for 2018 New CEO Richard Peters ex $SNY New CMO… https://t.co/y5Jc6cF6EB
November 19th 2017, 3:11pm
Ezehtim @Ezehtim
@normstorm that would assume he has the best interest of shareholders in mind. Check out $MACK
November 18th 2017, 9:11pm
TraderSilver1 @TraderSilver1
@Lblegend33 Knew that was coming reminds me of $Mack management how many shs outstanding for SGYP know ? 250-300m ?… https://t.co/2Ugaq5VHjw
November 15th 2017, 10:11am
storminvestor @storminvestor
Analysts Anticipate Merrimack Pharmaceuticals, Inc. $MACK Will Announce Quarterly Sales of $33.00 Million https://t.co/mNtvSyFlX7
November 14th 2017, 10:11pm
contraryguy @contraryguy
@cycleflyer Yeah, it's not as bad a deal as some (think $MACK) but if the max return is 1.5B for a 2.5B market cap… https://t.co/5nWLInGgxK
November 14th 2017, 8:11am
stocknewstimes @stocknewstimes
Brokerages Set Merrimack Pharmaceuticals, Inc. $MACK PT at $64.53 https://t.co/RPoYtQy12E
November 14th 2017, 8:11am
WeekHerald @WeekHerald
Merrimack Pharmaceuticals $MACK Getting Somewhat Favorable Media Coverage, Study Shows https://t.co/LS2K9zqhFI
November 14th 2017, 7:11am
WatchlistN @WatchlistN
Merrimack Pharmaceuticals $MACK Getting Somewhat Favorable Media Coverage, Study Shows https://t.co/uq4LPchirj
November 14th 2017, 2:11am
confcalltran @confcalltran
Tender offer statement by Issuer https://t.co/lAucQbE5jf $MACK
November 13th 2017, 7:11am
StockTexts @StockTexts
$MACK Merrimack Pharmaceuticals, Inc. SEC Filing: Form 8-K https://t.co/kAedXnmkbU
November 13th 2017, 7:11am
confcalltran @confcalltran
The Company agreed to conduct the Tender Offer in connection with the settlement agreement that https://t.co/j0yOrtVufC $MACK
November 13th 2017, 7:11am
filingBot @filingBot
@altafmubaraki there is a new form 8-K filing for $MACK https://t.co/jFSZpMNw3K Please RT.
November 13th 2017, 7:11am
filingBot @filingBot
@altafmubaraki there is a new form SC TO-I/A filing for $MACK https://t.co/TRaLBAeVe4 Likes and RTs apprechiated
November 13th 2017, 7:11am
emq_news @emq_news
Merrimack Pharmaceuticals, Inc. $MACK Shares Sold by Teachers Advisors LLC https://t.co/VrxZiZlIxR
November 12th 2017, 5:11am
TickerReport @TickerReport
Merrimack Pharmaceuticals, Inc. $MACK Shares Sold by Teachers Advisors LLC https://t.co/Pav3KW4ToT
November 12th 2017, 5:11am
TickerReport @TickerReport
Merrimack Pharmaceuticals, Inc. $MACK Shares Sold by Teachers Advisors LLC https://t.co/4oD466h38D
November 12th 2017, 5:11am
philintrades101 @philintrades101
Merrimack Pharmaceuticals Inc. $MACK Stock Live Analysis 01-09-2017 #stockmarket https://t.co/Zuntq15arX
November 12th 2017, 12:11am
AmericanBanking @AmericanBanking
$MACK - Merrimack Pharmaceuticals, Inc. #MACK Expected to Post Quarterly Sales of $24.00 Million https://t.co/9k4E2cmtTM
November 11th 2017, 6:11am
intercooleronli @intercooleronli
Merrimack Pharmaceuticals, Inc. $MACK Expected to Post Quarterly Sales of $24.00 Million https://t.co/6Lvv6GIMey
November 11th 2017, 6:11am
ConsumerFeed @ConsumerFeed
Merrimack Pharmaceuticals, Inc. $MACK Expected to Post Quarterly Sales of $24.00 Million https://t.co/JkwWJJMMpg #acn
November 11th 2017, 6:11am
CFinancialNews @CFinancialNews
Merrimack Pharmaceuticals, Inc. $MACK Expected to Post Quarterly Sales of $24.00 Million https://t.co/hhB1Y2JOIx
November 11th 2017, 6:11am
AmericanBanking @AmericanBanking
Merrimack Pharmaceuticals, Inc. $MACK Expected to Post Quarterly Sales of $24.00 Million https://t.co/7B7687m990
November 11th 2017, 6:11am
storminvestor @storminvestor
Alliancebernstein L.P. Purchases 113,200 Shares of Merrimack Pharmaceuticals, Inc. $MACK https://t.co/YWrtPVQPzS
November 11th 2017, 5:11am
AlertTrade @AlertTrade
TREND REVERSAL UP ALERT: $MACK MERRIMACK PHARMACEUTICALS ? TradeIdeas via https://t.co/VS8RO1bzXJ to Free Trading Room
November 9th 2017, 2:11pm
ZolmaxNews @ZolmaxNews
Analysts Anticipate Merrimack Pharmaceuticals, Inc. $MACK Will Announce Earnings of -$1.30 Per Share https://t.co/S8Eqv7Zlqx
November 9th 2017, 1:11pm
CFinancialNews @CFinancialNews
Analysts Anticipate Merrimack Pharmaceuticals, Inc. $MACK Will Announce Earnings of -$1.30 Per Share https://t.co/9Xr8jApfDO
November 9th 2017, 1:11pm
TickerReport @TickerReport
Schwab Charles Investment Management Inc. Has $322,000 Holdings in Merrimack Pharmaceuticals, Inc. $MACK https://t.co/w4bB2dFQZY
November 9th 2017, 4:11am
emq_news @emq_news
Schwab Charles Investment Management Inc. Has $322,000 Holdings in Merrimack Pharmaceuticals, Inc. $MACK https://t.co/5UzXKLRBnZ
November 9th 2017, 4:11am
TickerReport @TickerReport
Schwab Charles Investment Management Inc. Has $322,000 Holdings in Merrimack Pharmaceuticals, Inc. $MACK https://t.co/HTq3tQ1tqs
November 9th 2017, 4:11am
crwenewswire @crwenewswire
$MACK 's Numbers Revealed https://t.co/UjIUOAyJPJ
November 9th 2017, 2:11am
WatchMust @WatchMust
Merrimack Pharmaceuticals Inc. $MACK Stock Live Analysis 01-09-2017 #stock https://t.co/OyZiy1bmo5
November 8th 2017, 9:11pm
storminvestor @storminvestor
Cambridge Trust Co. Reduces Position in Merrimack Pharmaceuticals, Inc. $MACK https://t.co/uBxt6DnjBJ
November 8th 2017, 1:11pm
SPNewsAnalysis @SPNewsAnalysis
Cambridge Trust Co. Reduces Position in Merrimack Pharmaceuticals, Inc. $MACK https://t.co/cFT3sybWGi
November 8th 2017, 1:11pm
Allstocknews @Allstocknews
$MACK New Form SC TO-I/A for Merrimack Pharmaceuticals From our Stock News Alerts App
November 8th 2017, 12:11pm
StockTexts @StockTexts
$MACK $MACK Merrimack Pharmaceuticals, Inc. SEC Filing: Form SC TO-I/A https://t.co/F4uq6Fgk1K
November 8th 2017, 12:11pm
confcalltran @confcalltran
Tender offer statement by Issuer https://t.co/Urr5HD5F6T $MACK
November 8th 2017, 12:11pm
VisualStockRSRC @VisualStockRSRC
$MACK - Amended Tender Offer Statement by Issuer (sc To-i/a) https://t.co/dSeNstl72Q
November 8th 2017, 12:11pm
filingBot @filingBot
@altafmubaraki there is a new form SC TO-I/A filing for $MACK https://t.co/FhSEc0fuez Fav if you like.
November 8th 2017, 12:11pm
Allstocknews @Allstocknews
$MACK New Form 10-Q for Merrimack Pharmaceuticals From our Stock News Alerts App
November 8th 2017, 12:11pm
StockTexts @StockTexts
$MACK Merrimack Pharmaceuticals, Inc. SEC Filing: Form 10-Q https://t.co/82wI0FM950
November 8th 2017, 11:11am
VisualStockRSRC @VisualStockRSRC
$MACK - Quarterly Report (10-q) https://t.co/XDMVkmAoKr
November 8th 2017, 11:11am
confcalltran @confcalltran
Merrimack Pharmaceuticals Just Filed Its Quarterly Report: 6. Net Income (Loss... https://t.co/6eAbXj4Ijd $MACK
November 8th 2017, 11:11am
trumptrackerbot @trumptrackerbot
$MACK - 10-Q - or medical devices. In October 2017, President Trump signed a second Executive Order allowing for - https://t.co/lkOWlSdpGR
November 8th 2017, 11:11am
trumptrackerbot @trumptrackerbot
$MACK - 10-Q - measures was passed by the U.S. Senate. The Trump Administration has also taken executive actions - https://t.co/Xz84nroGij
November 8th 2017, 11:11am
filingBot @filingBot
@altafmubaraki there is a new form 10-Q filing for $MACK https://t.co/2l3kEapgaY Fav if you like.
November 8th 2017, 11:11am
marketexclusive @marketexclusive
Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Files An 8-K Results of Operations and Financial Condition https://t.co/bVKCS6tgda $MACK
November 8th 2017, 11:11am
investmorris @investmorris
Merrimack reports Q3 results; shares ahead 10% premarket $MACK https://t.co/TUb3RvF6nQ
November 8th 2017, 9:11am
stockspastor @stockspastor
Merrimack reports Q3 results; shares ahead 10% premarket $MACK https://t.co/LJmwHjFLpY https://t.co/myIRsFRn5a
November 8th 2017, 9:11am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.